IVA•benzinga•February 20, 2025 at 09:01 PM

Inventiva And Hepalys Launch Phase 1 Trial Of Lanifibranor In Japan For MASH, Targeting Japanese Market With 32 Participants; Results May Lead To Phase 3; Milestone In Partnership For Expansion In Japan And South Korea

No summary available.

Read the full article from the original source for complete details and context.

Article published on February 20, 2025 by benzinga